UROY (UROY)

$4.18 +3.08% on the day Market cap $604M 52-week range $2.56 to $5.52 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

UROY's free cash flow isn't comparable to its market value here, so a cash-flow reverse DCF doesn't give a meaningful answer. The Modeling tab works from revenue and margins instead.

Fundamental grade

C

Five factors scored 1 to 9 from UROY's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation6
Profitability6
Growth9
Financial health3

Results from SEC filings

Fiscal years, from UROY's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year202420252026
Revenue$31M$11M$187M
Net income$14M-$5M$40M
Free cash flow———
EPS (diluted)$0.12-$0.04$0.29
Operating margin16.3%-30.7%25.9%

Where the revenue comes from

Revenue by products, fiscal 2026. Every breakdown, year by year.

Sales of Uranium Inventory$187M100%
Royalty Revenue$145,0000%

Superinvestors who own UROY

From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Joel Greenblatt
Gotham Asset Management
New position $128,8670.0%Q2 2026

Insider buying

Open-market purchases by UROY's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of UROY in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when UROY trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

Are UROY insiders buying the stock?

No open-market insider purchases of UROY in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own UROY?

1 of the superinvestors Investingly tracks hold UROY in their latest 13F, including Joel Greenblatt.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.